Norgine submits Marketing Authorisation Application to the European Medicines Agency for eflornithine (difluoromethylornithine [DFMO]) in high-risk neuroblastoma
Back to media releasesNext media release LONDON, Jan. 7, 2025 /PRNewswire/ --…
SciSparc Announces Renewal of Approval by Israeli Medical Cannabis Agency for its Clinical Trial in Children with Autism Spectrum Disorder
TEL AVIV, Israel, Dec. 31, 2024 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq:…
CACI Awarded $290 Million Contract to Provide AI and Geospatial Expertise to the National Geospatial-Intelligence Agency (NGA)
RESTON, Va.--(BUSINESS WIRE)--CACI International Inc (NYSE: CACI) announced today that it is…
Altair Signs Collaboration Agreement with the European Space Agency
Altair software available to organizations through ESA Partnership Initiative for Commercialisation (EPIC)…